The predictive value of EGF A61G gene polymorphism in third-line treatment with cetuximab and irinotecan of patients with metastatic colorectal cancer

Karen-Lise Garm Spindler, Anders Jakobsen

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

OriginalsprogEngelsk
Publikationsdato2008
StatusUdgivet - 2008
BegivenhedDSKO's Årsmøde - Vejle, Danmark
Varighed: 10. apr. 200810. apr. 2008

Konference

KonferenceDSKO's Årsmøde
LandDanmark
ByVejle
Periode10/04/200810/04/2008

Citer dette

@conference{7d608670437711dd9fbe000ea68e967b,
title = "The predictive value of EGF A61G gene polymorphism in third-line treatment with cetuximab and irinotecan of patients with metastatic colorectal cancer",
author = "Spindler, {Karen-Lise Garm} and Anders Jakobsen",
year = "2008",
language = "English",
note = "null ; Conference date: 10-04-2008 Through 10-04-2008",

}

The predictive value of EGF A61G gene polymorphism in third-line treatment with cetuximab and irinotecan of patients with metastatic colorectal cancer. / Spindler, Karen-Lise Garm; Jakobsen, Anders.

2008. Poster session præsenteret på DSKO's Årsmøde, Vejle, Danmark.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

TY - CONF

T1 - The predictive value of EGF A61G gene polymorphism in third-line treatment with cetuximab and irinotecan of patients with metastatic colorectal cancer

AU - Spindler, Karen-Lise Garm

AU - Jakobsen, Anders

PY - 2008

Y1 - 2008

M3 - Poster

ER -